BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 9160528)

  • 1. Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Vaccine; 1997 Apr; 15(5):575-82. PubMed ID: 9160528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of wild-type and severe combined immunodeficiency mice against an intranasal challenge by passive immunization with monoclonal antibodies to the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.
    Pal S; Bravo J; Peterson EM; de la Maza LM
    Infect Immun; 2008 Dec; 76(12):5581-7. PubMed ID: 18809664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Infect Immun; 1997 Aug; 65(8):3361-9. PubMed ID: 9234798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection.
    Cotter TW; Meng Q; Shen ZL; Zhang YX; Su H; Caldwell HD
    Infect Immun; 1995 Dec; 63(12):4704-14. PubMed ID: 7591126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection.
    Peterson EM; Cheng X; Motin VL; de la Maza LM
    Infect Immun; 1997 Jul; 65(7):2693-9. PubMed ID: 9199438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection.
    Ramsey KH; Cotter TW; Salyer RD; Miranpuri GS; Yanez MA; Poulsen CE; DeWolfe JL; Byrne GI
    Infect Immun; 1999 Jun; 67(6):3019-25. PubMed ID: 10338514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge.
    Pal S; Luke CJ; Barbour AG; Peterson EM; de la Maza LM
    Vaccine; 2003 Mar; 21(13-14):1455-65. PubMed ID: 12615442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
    Pal S; Peterson EM; Rappuoli R; Ratti G; de la Maza LM
    Vaccine; 2006 Feb; 24(6):766-75. PubMed ID: 16199110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Infect Immun; 2001 Oct; 69(10):6240-7. PubMed ID: 11553566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis.
    Whittum-Hudson JA; Rudy D; Gèrard H; Vora G; Davis E; Haller PK; Prattis SM; Hudson AP; Saltzman WM; Stuart ES
    Vaccine; 2001 Jul; 19(28-29):4061-71. PubMed ID: 11427283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge.
    Pal S; Davis HL; Peterson EM; de la Maza LM
    Infect Immun; 2002 Sep; 70(9):4812-7. PubMed ID: 12183524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mimicry of a neutralizing epitope of the major outer membrane protein of Chlamydia trachomatis by anti-idiotypic antibodies.
    Brossay L; Villeneuve A; Paradis G; Coté L; Mourad W; Hébert J
    Infect Immun; 1994 Feb; 62(2):341-7. PubMed ID: 7507888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of neutralization of Chlamydia trachomatis infection by high avidity monoclonal antibodies to surface-exposed major outer membrane protein variable domain IV.
    Degn LLT; Bech D; Christiansen G; Birkelund S
    Mol Immunol; 2023 Nov; 163():163-173. PubMed ID: 37801817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis.
    Batteiger BE; Rank RG; Bavoil PM; Soderberg LS
    J Gen Microbiol; 1993 Dec; 139(12):2965-72. PubMed ID: 7510322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Codon usage bias in Chlamydia trachomatis and the effect of codon modification in the MOMP gene on immune responses to vaccination.
    Zheng Y; Zhao WM; Wang H; Zhou YB; Luan Y; Qi M; Cheng YZ; Tang W; Liu J; Yu H; Yu XP; Fan YJ; Yang X
    Biochem Cell Biol; 2007 Apr; 85(2):218-26. PubMed ID: 17534403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Chlamydia trachomatis-specific Th2 clone does not provide protection against a genital infection and displays reduced trafficking to the infected genital mucosa.
    Hawkins RA; Rank RG; Kelly KA
    Infect Immun; 2002 Sep; 70(9):5132-9. PubMed ID: 12183563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a neutralizing monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars.
    Qu Z; Cheng X; de la Maza LM; Peterson EM
    Infect Immun; 1993 Apr; 61(4):1365-70. PubMed ID: 7681045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis.
    Zhang YX; Stewart S; Joseph T; Taylor HR; Caldwell HD
    J Immunol; 1987 Jan; 138(2):575-81. PubMed ID: 3540122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses.
    Dong-Ji Z; Yang X; Shen C; Lu H; Murdin A; Brunham RC
    Infect Immun; 2000 Jun; 68(6):3074-8. PubMed ID: 10816446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes.
    Igietseme JU; Murdin A
    Infect Immun; 2000 Dec; 68(12):6798-806. PubMed ID: 11083798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.